ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,289.12
-0.61%
US Tech 100
18,150.00
-0.45%
다우존스 지수
39,571.94
-0.76%
Bitcoin
69,404.16
-1.04%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. AnaptysBio Inc (ANAB)

  7. AnaptysBio Inc (ANAB) 뉴스

ANAB

AnaptysBio (ANAB)

AnaptysBio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ANAB
일자시간출처헤드라인심볼기업
2024/05/1005:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
2024/05/1005:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2024/05/1005:15GlobeNewswire Inc.Anaptys Announces First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ANABAnaptysBio Inc
2024/05/1005:10GlobeNewswire Inc.Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)NASDAQ:ANABAnaptysBio Inc
2024/05/1005:05GlobeNewswire Inc.Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli RoyaltiesNASDAQ:ANABAnaptysBio Inc
2024/05/0701:59Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ANABAnaptysBio Inc
2024/04/2422:00PR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:ANABAnaptysBio Inc
2024/03/1205:41Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANABAnaptysBio Inc
2024/03/1205:36Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANABAnaptysBio Inc
2024/03/1205:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2024/02/2923:15GlobeNewswire Inc.Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual MeetingNASDAQ:ANABAnaptysBio Inc
2024/02/1500:01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANABAnaptysBio Inc
2024/02/1422:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANABAnaptysBio Inc
2024/01/3123:15GlobeNewswire Inc.Anaptys to Present at Guggenheim’s 6th Annual Biotechnology ConferenceNASDAQ:ANABAnaptysBio Inc
2024/01/1009:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/1009:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0607:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0607:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0606:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0606:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0606:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0606:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0606:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANABAnaptysBio Inc
2024/01/0606:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2023/11/2806:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2023/11/2806:15GlobeNewswire Inc.Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa PharmaceuticalsNASDAQ:ANABAnaptysBio Inc
2023/11/0806:15GlobeNewswire Inc.Anaptys Named a BioSpace 2024 Best Places to Work WinnerNASDAQ:ANABAnaptysBio Inc
2023/11/0305:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANABAnaptysBio Inc
2023/11/0305:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANABAnaptysBio Inc
2023/11/0305:15GlobeNewswire Inc.Anaptys Announces Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ANABAnaptysBio Inc
 검색 관련기사 보기:NASDAQ:ANAB

최근 히스토리

COIN
TKGGBP
Takamaka Green Coin
BIT
UB7XW8
Unicredit Bank
AMEX
CNET
NYSE
STT-E.CL
State Street
NASDAQ
EMBCV
Embecta
COIN
PRAIUSD
Proto Rai Reflex Index
BFNX
CSXUSD
COIN
ACAAGBP
ASX
HML
Henry Morgan
LSE
CU35
Citi Fun 25
TSXV
BITK
BlockchainK2
EU
3177T
3177T
BIT
S28972
Societe Generale Effekten
AQSE
3GOL.GB
WisdomTree Multi Asset I...
LSE
ICMI
LSE
NWOR
National World
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유